Concentra Group Holdings Parent (CON) drew attention after announcing a new medical center in Goodyear, Arizona, increasing its statewide presence to 17 locations in a rapidly expanding industrial corridor.

Concentra Group Holdings Parent's latest expansion comes against a backdrop of strong momentum, with a 30 day share price return of 15.09% and a year to date share price return of 50.13%. The 1 year total shareholder return is 43.50%, suggesting investors have recently been rewarding its growth and risk profile.

If you are looking beyond Concentra Group Holdings Parent and want more ideas in healthcare related growth stories, it could be worth checking out 38 healthcare AI stocks

With Concentra Group Holdings Parent trading at US$29.14 against an analyst price target of US$31.50 and an estimated intrinsic discount of about 45%, the key question is whether this signals a genuine value gap or if the market is already pricing in future growth.

Price to Earnings of 21.3x: Is It Justified?

Concentra Group Holdings Parent currently trades on a P/E of 21.3x, which aligns with a share price of $29.14 that screens as expensive relative to some of its own valuation checks.

The P/E ratio compares the current share price to earnings per share, so it effectively tells you how many years of current earnings the market is willing to pay for. For a healthcare services company like Concentra Group Holdings Parent, this often reflects expectations around the stability of earnings, the resilience of demand for occupational health services, and the quality of cash generation.

Here, the data sends a mixed signal. On one side, the stock is described as trading at about 45% below an estimate of future cash flow value of $53.34 and flagged as good value relative to the broader US Healthcare industry average P/E of 23.6x. On the other side, the same P/E of 21.3x is flagged as expensive compared both to peer companies on 18.1x and an estimated fair P/E of 20.6x. This suggests the current multiple sits slightly above a level the market could plausibly move toward if expectations cool.

Against healthcare peers overall, Concentra Group Holdings Parent looks cheaper on P/E. However, against its closer peer set and the model based fair ratio, the stock carries a premium that implies the market is already paying up somewhat for its earnings profile and forecast growth.

Result: Price-to-Earnings of 21.3x (ABOUT RIGHT)

However, investors in Concentra Group Holdings Parent still need to weigh risks such as execution on further expansion and any slowdown in revenue or net income growth.

Another View: What The SWS DCF Model Suggests

The P/E discussion presents Concentra Group Holdings Parent as slightly expensive compared with peers, but the SWS DCF model points in a different direction. With an estimated future cash flow value of $53.34 against a current price of $29.14, the stock is described as trading about 45% below that estimate. For investors, the key question is whether to place more weight on the earnings multiple or on the cash flow calculations.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Concentra Group Holdings Parent for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment on Concentra Group Holdings Parent looking mixed, this is a moment to check the numbers yourself and decide how compelling the risk reward trade off really is. To see how the concerns and potential upsides stack up side by side, start with 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Concentra Group Holdings Parent?

If Concentra Group Holdings Parent is on your radar, do not stop there, broaden your watchlist now so you are not relying on a single opportunity.

• Spot potential value opportunities early by scanning 44 high quality undervalued stocks that combine quality fundamentals with appealing prices.
• Strengthen your income focus by reviewing 7 dividend fortresses offering higher yields with an emphasis on resilience.
• Prioritize capital preservation by filtering for 69 resilient stocks with low risk scores that score well on stability and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.